-
公开(公告)号:US20090155257A1
公开(公告)日:2009-06-18
申请号:US12256349
申请日:2008-10-22
申请人: CAMELLIA W. ADAMS , ANDREW C. CHAN , CRAIG W. CROWLEY , HENRY B. LOWMAN , GERALD R. NAKAMURA , LEONARD G. PRESTA
发明人: CAMELLIA W. ADAMS , ANDREW C. CHAN , CRAIG W. CROWLEY , HENRY B. LOWMAN , GERALD R. NAKAMURA , LEONARD G. PRESTA
CPC分类号: C07K16/2887 , A61K2039/505 , C07K2317/24 , C07K2317/41 , C07K2317/52 , C07K2317/522 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/72 , C07K2317/73 , C07K2317/732 , C07K2317/734 , C07K2317/75 , C07K2317/92
摘要: The invention provides humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases.
摘要翻译: 本发明提供用于治疗CD20阳性恶性肿瘤和自身免疫疾病的人源化和嵌合抗CD20抗体。